Published in Transplant Proc on June 01, 1995
Childhood abuse and neglect among women outpatients with chronic mental illness. Hosp Community Psychiatry (1993) 1.64
Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil (1996) 1.48
Is immediate decompression of high voltage electrical injuries to the upper extremity always necessary? J Trauma (1996) 1.21
Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant (2005) 1.20
[Desmosomes in the cytoplasm of dedifferentiated keratinocytes of squamous cell carcinoma]. Arch Klin Exp Dermatol (1970) 1.16
Alcohol use and burn injury. J Burn Care Rehabil (1991) 1.15
Is the transplant-preserving management of renal allograft rupture justified? Br J Urol (1995) 1.14
Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem (2000) 1.13
Synthetic burn dressings: round table discussion. J Burn Care Rehabil (1987) 1.07
Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol (1999) 1.05
Simultaneous contralateral testicular metastasis from a renal clear cell carcinoma. Scand J Urol Nephrol (1999) 1.04
Burn patients, then and now. Burns (1999) 1.03
Fungi and pollen exposure in the first months of life and risk of early childhood wheezing. Thorax (2009) 0.98
Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int (2006) 0.96
Surveillance of burn wound infections: a proposal for definitions. J Burn Care Rehabil (1998) 0.91
[Structure and function of the granular nuclear bodies. Investigation on the squamous cell carcinoma]. Arch Klin Exp Dermatol (1970) 0.91
Serial measurements increase the accuracy of laser Doppler assessment of burn wounds. J Burn Care Rehabil (2003) 0.89
Diagnosis-related groupings (DRGs) and wound closure: roundtable discussion. J Burn Care Rehabil (1987) 0.88
Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet (1997) 0.88
Prognosis and treatment of burns. West J Med (1996) 0.86
Nephrogenic adenoma in children. Case report and review of literature. Eur J Pediatr Surg (1997) 0.83
Full-thickness burn to the hand from an automobile airbag. J Burn Care Rehabil (2000) 0.83
Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation. Transplant Proc (1994) 0.80
Ureterosciatic hernia. Scand J Urol Nephrol (1996) 0.80
Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study. Ren Fail (2004) 0.80
Chemolysis of struvite stones by acidification of artificial urine--an in vitro study. Scand J Urol Nephrol (2001) 0.79
Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron (1982) 0.78
Improved accuracy of burn wound assessment using laser Doppler. J Trauma (1996) 0.78
Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of alfentanil. Anesthesiology (1999) 0.78
Value of prostate-specific antigen as a tumor marker. Eur Urol (1993) 0.78
Withdrawal from positive end-expiratory pressure. Surgery (1978) 0.78
Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine. J Trauma (1989) 0.78
Comprehensive evaluation of basic living skills. Am J Occup Ther (1976) 0.78
Hydronephrosis after aorto bifemoral graft surgery: a marker for late graft complications. Scand J Urol Nephrol (1999) 0.77
Dr. Paul Unna's boot and early ambulation after skin grafting the leg: a survey of burn centers and a report of 20 cases. Plast Reconstr Surg (1982) 0.77
Experience with skeletal immobilization after excision and grafting of severely burned hands. J Trauma (1985) 0.77
Adjunctive interventions for burn pain control: comparison of hypnosis and ativan: the 1993 Clinical Research Award. J Burn Care Rehabil (1994) 0.76
Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients. Kidney Blood Press Res (2003) 0.76
Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients. Transplant Proc (2005) 0.76
The effect of tumor necrosis factor alpha on a human renal cell carcinoma xenotransplanted into nude mice: comparison of intravenous and intraperitoneal injection. Oncology (1995) 0.76
Measurement of NO synthesis in humans by L-[15N2]arginine: application to the response to vaccination. Am J Physiol (1997) 0.76
A new type of artificial urinary calculi: in vitro study by spiral CT. Invest Radiol (2000) 0.76
N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation. Scand J Urol Nephrol (1996) 0.75
[Various forms of endoplasmic reticulum in dedifferenciated keratinocytes. Observations in squamous cell carcinoma]. Arch Dermatol Forsch (1972) 0.75
Use of hyperbaric oxygen. Clin Infect Dis (1993) 0.75
The fourth quinquennium: 1984 to 1988. J Burn Care Rehabil (1993) 0.75
Clinical and immunologic characteristics of transplant recipients with recurrent acute rejection episodes. Transplant Proc (1996) 0.75
[An expert system of aiding decision making in breast pathology connected to a clinical data base]. Bull Cancer (1987) 0.75
Who speaks for the little burn? Burns (1996) 0.75
[Anesthesia in angiography of the carotid arteries]. Neurol Neurochir Pol (1985) 0.75
Manifestation of metabolic risk factors after renal transplantation: III. Impact on cerebrocardiovascular complications. Transplant Proc (1995) 0.75
Clinical and immunological characteristics of transplant recipients with recurrent acute rejection episodes. Transplant Proc (1997) 0.75
Anesthesia-assisted procedures in a burn intensive care unit procedure room: benefits and complications. J Burn Care Rehabil (1993) 0.75
[Primary oxalosis in childhood. Plain film findings during the course of the disease (author's transl)]. Rofo (1982) 0.75
[Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma]. Urologe A (1993) 0.75
[Effect of extracorporeal hemoperfusion on the elimination of carbromal in carbromal poisoning]. Verh Dtsch Ges Inn Med (1978) 0.75
Manifestation of metabolic risk factors after renal transplantation: II. Impact of maintenance therapy. Transplant Proc (1995) 0.75
Meperidine disposition in burn patients. Res Commun Chem Pathol Pharmacol (1986) 0.75
Immunologic disorders in posttransplant lymphoma: therapeutic implications. Transplant Proc (1996) 0.75
The role of autopsy on patients with burns. J Burn Care Rehabil (2000) 0.75
Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant (1997) 0.75
Contact burns of the hand. Pediatrics (1987) 0.75
Chronic allograft destruction vs chronic allograft rejection. Transplant Proc (1994) 0.75
[Parathyroid hormone and cyclic AMP in kidney failure]. Verh Dtsch Ges Inn Med (1978) 0.75
Cold ischemia, histocompatibility, donor and recipient age: impact on early lymphocyte subsets and transplant outcome. Transplant Proc (1996) 0.75
[Computer tomographic diagnosis of pericardial effusions (author's transl)]. Rofo (1979) 0.75
[Acute tension pneumocephalus as a complication of surgical procedures of the posterior cranial fossa in prone position]. Neurol Neurochir Pol (1987) 0.75
Chemolysis of artificial cystine stones (BON(N)-STONES) in vitro using a new dissolution device: first results. J Endourol (2000) 0.75
[The Churg-Strauss syndrome with cerebral seizures and terminal kidney failure]. Dtsch Med Wochenschr (1997) 0.75
Treatment of a human renal cell carcinoma in nude mice with recombinant human tumor necrosis factor alpha and etoposide. J Urol (1993) 0.75
Predictive value of immunological parameters in the early diagnosis of cytomegalovirus infection in renal transplantation. Transplant Proc (1993) 0.75
[Barbiturate-induced coma in the treatment of severe cranio-cerebral injuries in children]. Pol Tyg Lek (1987) 0.75
Results of donor kidney pairs after local versus HLA-dependent allocation. Transplant Proc (1997) 0.75
[Digitoxin metabolism in patients with kidney insufficiency]. Verh Dtsch Ges Inn Med (1978) 0.75
[Tension pneumocephalus as a perioperative complication of neurosurgical procedures]. Neurol Neurochir Pol (1986) 0.75
[Surgical interventions of the adrenal gland. Diagnosis and results of treatment]. Urologe A (1994) 0.75
Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens. Transpl Int (1996) 0.75
[Recurrent corneal swelling accompanying intermittent hemodialysis in terminal kidney failure (author's transl(]. Klin Monbl Augenheilkd (1981) 0.75
Blood flow and oxygen extraction in ischaemic and normal regions of the myocardium following acute coronary artery ligation. J Physiol (1973) 0.75
[56-year-old man with acrocyanosis, livedo reticularis, renal failure and arterial hypertension. Cholesterol embolism syndrome (CES)]. Internist (Berl) (1998) 0.75
In-vivo stimulation of cell-proliferation of 2 human tumor xenograft lines by granulocyte-macrophage colony-stimulating factor (gm-csf). Oncol Rep (1994) 0.75
[Continuous arteriovenous hemofiltration in acute postoperative and post-traumatic kidney failure]. Chirurg (1983) 0.75
Tumors after transplantation: are there associated factors? Transplant Proc (1996) 0.75
The burn surgeon and the need for critical care certification. J Burn Care Rehabil (1990) 0.75
Hemoglobin oxygen affinity and acid-base status in blood of chronic hemodialysis patients. Adv Exp Med Biol (1994) 0.75
[MR tomography following kidney transplantation]. Rofo (1987) 0.75
Free plasma amino acids in patients with multiple myeloma. J Chemother (1989) 0.75
[Regression of cerebral post-transplantation lymphoma under cyclosporin A reduction]. Klin Wochenschr (1990) 0.75
Immunologic diagnostic and therapeutic aspects of cytomegalovirus, human herpes virus-6, and Epstein-Barr virus disease posttransplantation. Transplant Proc (1996) 0.75
Tumour induction as a consequence of immunosuppression after renal transplantation. Int Urol Nephrol (1997) 0.75
Dilemma: maintenance therapy enhances sclerogenic risk profile. Transplant Proc (1996) 0.75
Recipe for postgraft antimicrobial wound cover. J Burn Care Rehabil (1995) 0.75
Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia. Transplant Proc (1994) 0.75